Poor people in developing countries are still not getting access to many life-saving medicines five years after a trade declaration that rich countries should put patients before profits, campaigners said on Tuesday...Oxfam and AIDS groups said...rich countries, particularly the United States, were bullying developing countries to impose stricter patent rules in order to preserve pharmaceutical monopolies...[An example is]...a dispute over the cancer drug Glivec, made by...Novartis...An Indian court in January rejected its patent application for Glivec, but Novartis is fighting back, arguing that the principle of intellectual property protection must be protected if innovation is to flourish.